Market Place
Sourcing Support
All News #Library
Others
Cellares Attracts $257M Series D To Build Sites In Japan, Europe
28 Jan 2026 //
FIERCE PHARMA
Cellares Appoints Ali Soleymannezhad As Chief Commercial Officer
01 Dec 2025 //
PHARMIWEB
Cellares Adds Ex-Kite Exec Christopher McDonald as Advisor
22 Sep 2025 //
BUSINESSWIRE
Cellares Cell Shuttle Receives FDA AMT Designation
01 Apr 2025 //
CONTRACTPHARMA
Cellares Appoints Ossama as COO, Former Novartis & Lonza Leader
12 Nov 2024 //
BUSINESSWIRE
Cellares Completes New cGMP Cell Shuttle in Bridgewater, NJ
05 Sep 2024 //
CONTRACT PHARMA
Cellares Completes First cGMP Cell Shuttle at IDMO Smart Factory in New Jersey
05 Sep 2024 //
BUSINESSWIRE
Cellares Appoints Justin McAnear as CFO and Jonathan Butler as General Counsel
03 Sep 2024 //
BUSINESSWIRE
Cellares Appoints CFO and General Counsel
03 Sep 2024 //
CONTRACT PHARMA
Shaw Appointed to Cellares Advisory Board to Advance Cell Therapy Manufacturing
26 Mar 2024 //
BUSINESSWIRE
Cellares to produce Cabaletta’s autoimmune CAR-T candidate
06 Nov 2023 //
ENDPTS
Cellares Announces Expanded Agreement with Bristol Myers Squibb
11 Oct 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.